Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin
- PMID: 8687105
Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin
Abstract
The necrosis of EMT-6 mammary murine tumors induced by photodynamic therapy (PDT) with Photofrin (PII) or disulfonated aluminum phthalocyanine (AlPcS2) was studied. Attention was given to the spontaneous evolution of angiogenesis and necrosis of such tumors in order to determine the most appropriate moment for treatment. On day 6 after tumor cell inoculation, mice were injected with photosensitizer followed by exposure to red light 24 h later, at which time optimal dye concentrations were reached in the tumor. Animals were sacrificed 3 h or 24 h after illumination and tissues were prepared for histology. Prominent cytopathic alterations were already observed at 3 h and there was massive necrosis at 24 h. In the case of PII vascular damage, congestion and hemorrhage were already present at 3 h and these changes account for the subsequent tumor necrosis through hemorrhagic infarction. With AlPcS2 these early vascular alterations were much less evident and only focal at 24 h, suggesting that AlPcS2-PDT mediated tumor necrosis involves to a large extent direct tumor cell damage.
Similar articles
-
Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.Anticancer Res. 1996 Jul-Aug;16(4A):1887-92. Anticancer Res. 1996. PMID: 8712717
-
Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.Laryngoscope. 1993 Sep;103(9):967-75. doi: 10.1288/00005537-199309000-00005. Laryngoscope. 1993. PMID: 8361317
-
High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.J Nucl Med. 1999 May;40(5):876-82. J Nucl Med. 1999. PMID: 10319764
-
Light scattering of human skin: a comparison between zinc (II)-phthalocyanine and photofrin II.J Photochem Photobiol B. 1996 Jan;32(1-2):3-9. doi: 10.1016/1011-1344(95)07209-8. J Photochem Photobiol B. 1996. PMID: 8725049 Review.
-
[Photodynamic therapy for early cervical cancer].Nihon Rinsho. 2004 Oct;62 Suppl 10:158-68. Nihon Rinsho. 2004. PMID: 15535226 Review. Japanese. No abstract available.
Cited by
-
Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.Br J Cancer. 1999 Jul;80(10):1533-41. doi: 10.1038/sj.bjc.6690557. Br J Cancer. 1999. PMID: 10408394 Free PMC article.
-
Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy.ChemMedChem. 2010 Jun 7;5(6):890-8. doi: 10.1002/cmdc.201000042. ChemMedChem. 2010. PMID: 20458713 Free PMC article.
-
Fighting Cancer with Corroles.Chem Rev. 2017 Feb 22;117(4):2711-2729. doi: 10.1021/acs.chemrev.6b00400. Epub 2016 Oct 19. Chem Rev. 2017. PMID: 27759377 Free PMC article. Review.
-
Serum albumin as a vehicle for zinc phthalocyanine: photodynamic activities in solid tumour models.Br J Cancer. 1996 Dec;74(12):1886-90. doi: 10.1038/bjc.1996.649. Br J Cancer. 1996. PMID: 8980386 Free PMC article.
-
Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.Br J Cancer. 1997;76(8):1021-8. doi: 10.1038/bjc.1997.502. Br J Cancer. 1997. PMID: 9376261 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources